IN ACCORDANCE WITH ITEM 601 OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THE EXHIBIT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [*] INDICATES THAT INFORMATION...Exclusive Option Agreement • November 1st, 2024 • MED EIBY Holding Co., LTD • Surgical & medical instruments & apparatus
Contract Type FiledNovember 1st, 2024 Company IndustryThis Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of January 28, 2022, in Shenzhen, the People’s Republic of China (“China” or the “PRC”):
IN ACCORDANCE WITH ITEM 601 OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THE EXHIBIT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [*] INDICATES THAT INFORMATION...Exclusive Option Agreement • November 9th, 2023 • MED EIBY Holding Co., LTD • Surgical & medical instruments & apparatus
Contract Type FiledNovember 9th, 2023 Company IndustryThis Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of January 28, 2022, in Shenzhen, the People’s Republic of China (“China” or the “PRC”):
IN ACCORDANCE WITH ITEM 601(B)(10)(IV) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THE EXHIBIT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [*] INDICATES THAT...Exclusive Option Agreement • March 9th, 2023 • MED EIBY Holding Co., LTD • Surgical & medical instruments & apparatus
Contract Type FiledMarch 9th, 2023 Company IndustryThis Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of January 28, 2022, in Shenzhen, the People’s Republic of China (“China” or the “PRC”):
Exclusive Option AgreementExclusive Option Agreement • January 17th, 2023 • MED EIBY Holding Co., LTD • Surgical & medical instruments & apparatus
Contract Type FiledJanuary 17th, 2023 Company IndustryThis Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of January 28, 2022, in Shenzhen, the People’s Republic of China (“China” or the “PRC”):